Mass. Federal Judge Allows Design Defect Claims To Move Forward In BioZorb Cases
BOSTON — A group of cases alleging that an implanted radiographic marker used to mark soft tissue sites during cancer treatment was defective and caused injuries survived a motion to dismiss...To view the full article, register now.
Already a subscriber? Click here to view full article